CASI PHARMACEUTICALS INC CASIF
ORD SHS · Common Stock · CUSIP G1933S101
- SectorHealth care
- IndustryPharmaceutical Preparations
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 20.6m as of 2025-12-31, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $0.11.
Trends to Q1 2026
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2022 | 1 |
| Q1 2023 | 21 |
| Q2 2023 | 20 |
| Q3 2023 | 20 |
| Q4 2023 | 19 |
| Q1 2024 | 21 |
| Q2 2024 | 24 |
| Q3 2024 | 21 |
| Q4 2024 | 23 |
| Q1 2025 | 24 |
| Q2 2025 | 25 |
| Q3 2025 | 22 |
| Q4 2025 | 16 |
| Q1 2026 | 1 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q2 2024 | 9 | 9 |
| Q3 2024 | 6 | 7 |
| Q4 2024 | 4 | 9 |
| Q1 2025 | 8 | 4 |
| Q2 2025 | 7 | 10 |
| Q3 2025 | 8 | 8 |
| Q4 2025 | 3 | 13 |
| Q1 2026 | 1 | 15 |
Calls vs puts
Options held, notional value, last 4 quarters. P/C = puts ÷ calls
Numbers
| Quarter | Calls | Puts | P/C |
|---|---|---|---|
| Q2 2025 | $0 | $0 | — |
| Q3 2025 | $1.8k | $0 | 0.00 |
| Q4 2025 | $935 | $0 | 0.00 |
| Q1 2026 | $0 | $0 | — |
Biggest buyers
| SIMPLEX TRADING, LLC | Added | +95 |
Biggest sellers
| Venrock Adviser, LLC | Sold out | -987.3k |
| Woodline Partners LP | Sold out | -133.4k |
| RENAISSANCE TECHNOLOGIES LLC | Sold out | -43.1k |
| TWO SIGMA INVESTMENTS, LP | Sold out | -23.8k |
| BANK OF AMERICA CORP /DE/ | Sold out | -19.9k |
| GEODE CAPITAL MANAGEMENT, LLC | Sold out | -18.8k |
| CITADEL ADVISORS LLC | Sold out | -14.0k |
| ROYAL BANK OF CANADA | Sold out | -9.9k |
| UBS Group AG | Sold out | -659 |
| WELLS FARGO & COMPANY/MN | Sold out | -505 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
He Wei-Wu
13D · may seek influence
+5.8 pts · filed 2026-05-18
Stated purposeOn April 17, 2026, ETP Global III Fund L.P. purchased a convertible note with the principal amount of US$5 million as the fourth tranche of the Issuer's US$20 million convertible note financing pursuant to certain convertible note purchase agreement (the "Purchase Agreement") between ETP Global III Fund L.P. and the Issuer dated December 11, 2025. A convertible note with a principal amount of US$5 million has been issued to the Purchaser on the same date (the "Convertible Note"). The Purchaser has the right to convert such note into the Company's ordinary shares, par value US$0.0001 per share (the "Ordinary Shares") at any time from and including the 91st day after the issuance thereof to and including the maturity date at a conversion price of the volume weighted average closing price of … Full filing |
58.8% |
| Panacea Innovation Ltd 13D · may seek influence +2.6 pts · filed 2025-12-17 | 22.5% |
| Huang James 13G · passive investor filed 2025-07-23 | 13.8% |
| Chen Zhenfeng M 13G · passive new · filed 2025-11-26 | 11.0% |
| Venrock Healthcare Capital Partners III, L.P. 13G · passive investor filed 2026-02-17 | 9.2% |
| SPARKLE BYTE LTD 13D · may seek influence filed 2026-01-20 | 5.0% |
Fell to 5% or below in the last year: Foresite Capital Fund VI LP (0.0%, 2026-02-13), Ho Chi Sing (4.8%, 2026-01-20)
Insider purchases and sales in Q1 2026
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q1 2026.
Holders, Q1 2026
| Manager | Shares | Change |
|---|---|---|
| SIMPLEX TRADING, LLC 0.00% of their portfolio | 228 $25 | Added +95 |